ESCMID Global 2025: The challenges of eliminating viral hepatitis
At the 35th European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global conference in Vienna, Austria, held from April 11-15, the challenges of eliminating viral hepatitis were discussed.
In 2024, the World Health Organization (WHO) reported that aside from tuberculosis, viral hepatitis was the most common cause of mortality due to infectious diseases worldwide. Furthermore, despite a slow decrease in the global incidence of viral hepatitis B (HBV) and C (HCV) in recent years, mortality due to these viruses has been increasing. In 2016, WHO launched the Global Health Sector Strategy, which aimed to end viral hepatitis by 2030, defining elimination as a 90% reduction in incidence and 65% reduction in mortality for HBV and HCV from 2015 to 2030. One challenge to achieving this goal is the proportion of undiagnosed individuals living with viral hepatitis. According to WHO, 254 million people globally were estimated to have HBV in 2022, but only approximately 10% had been diagnosed. Likewise, 50 million people globally were estimated to have HCV in 2022, but only approximately 30% had been diagnosed.
One current strategy to closing this gap and providing patients with diagnoses and treatments is reflex testing, which is the automatic addition of testing based upon initial test results. With one patient-provided sample, reflex testing can provide complete data for diagnosis, staging, coinfection, and management strategies. For example, if a patient tests positive for the hepatitis B surface antigen, this sample could be reflexed and tested for hepatitis D virus (HDV) antibodies (anti-HDV). Furthermore, if the patient tests positive for anti-HDV, this sample could be reflexed and tested for HDV-RNA. Some advantages of reflex testing include the automatic addition of testing, the fact that active infections can be confirmed using one sample, the streamlining of the diagnostic process without needing additional patient visits, reduced diagnostic delays, increased linkage to care, improved patient outcomes, and enhanced efficiency in laboratory and clinical workflows.
The advantages of reflex testing have also been evidenced in primary literature. In a retrospective 2023 study by Rohit Nathani and colleagues that was published in the Journal of Viral Hepatitis, over 11,000 HBV patients were studied for five years, and 12.9% of patients were subsequently screened for HDV infection. Researchers confirmed that 18% of the patients who were found to be positive for HDV would have been missed if the researchers had followed risk-based screening guidelines. Furthermore, the European Association for the Study of the Liver published Clinical Practice Guidelines on HDV in 2023 in which it recommended that all HBV patients should be screened for anti-HDV antibodies at least once, due to evidence that reflex testing of anti-HDV in HBV-positive patients resulted in a five-fold increase in HDV diagnoses. Overall, reflex testing can be useful for generating prevalence estimates and finding undiagnosed individuals.
Another strategy to close the gap of undiagnosed individuals living with viral hepatitis is opt-out testing, which is a proactive screening system. This strategy was tested in London hospitals, in which any patient who entered the emergency department and had a blood draw was automatically tested for bloodborne viruses. In a two-year period (April 2022-March 2024), nearly 2,000 HBV infections, over 760 HCV infections, and almost 400 human immunodeficiency virus infections were newly diagnosed. Closing the gap of undiagnosed individuals is clinically important to link patients to the appropriate care, and also offers epidemiological importance to reduce the transmission of these infections.
One particular challenge in eliminating viral hepatitis is reaching populations that may experience obstructions in accessing proper healthcare services. These 'hard-to-reach' populations include people who inject drugs, prisoners, immigrant communities, homeless individuals, individuals with mental health disorders, and racial and ethnic minorities. Particular strategies for reaching these populations can include integrating hepatitis care into existing healthcare, expanding access to screening and treatment, expanding harm reduction services, and addressing stigma and lack of awareness. Altogether, effective hepatitis management and elimination strategies require a collaborative and multidisciplinary approach involving the community and healthcare professionals.
"ESCMID Global 2025: The challenges of eliminating viral hepatitis" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 hours ago
- Yahoo
As measles spreads across the Americas, outbreaks in Mexico and Canada have also turned deadly
As measles cases in the United States continue to mount, neighboring countries Canada and Mexico are also experiencing significant outbreaks – all of which have been linked to at least one death. On Thursday, the chief medical officer of health of the Canadian province Ontario announced that an infant who was born prematurely with a measles infection had died. 'The infant contracted the virus before birth from their mother, who had not received the measles, mumps and rubella (MMR) vaccine,' Dr. Kieran Moore said in a statement. 'While measles may have been a contributing factor in both the premature birth and death, the infant also faced other serious medical complications unrelated to the virus.' At least four people have died from measles in Mexico in 2025, and three people have died in the US: two children in Texas and one adult in New Mexico, all of whom were unvaccinated. This years' measles outbreaks are the biggest that Canada and Mexico have seen in decades, and the World Health Organization has warned that the 'overall risk of measles in the Americas Region is considered high.' Low vaccination rates are a key driver of this elevated risk assessment, the agency said. Mexico has reported at least 1,520 measles cases as of late May, according to data from the Pan American Health Organization. Canada reached measles elimination status in 1998, meaning that there has not been continuous spread of the virus for more than a year. But there have already been more cases reported so far this year than there were in the previous 27 years combined. At least 2,755 measles cases have been reported in Canada so far this year, according to federal data that was last updated on Monday, the vast majority of those which have been in Ontario residents. And the US has reported at least 1,168 measles cases so far this year, according to federal data published Friday – nearly 80% of which are associated with an outbreak centered in West Texas that has spread to New Mexico, Oklahoma and possibly Canada. It's the second highest number of cases that the US has reported since achieving measles elimination status in 2000. Significant shares of the measles outbreaks in the US, Canada and Mexico have been concentrated in Mennonite communities that are closely connected to each other – and that have historically had low vaccination rates due largely to minimal interactions with formal health care systems. However, in a recent webinar, experts from the Pan American Health Organization did not formally link outbreaks in the three countries to each other. 'The outbreak [in Mexico] started in Chihuahua, at the heart of Mennonite communities, who were very close to Texas through the border, but they're also close to other Mennonite communities in Canada,' Dr. Alvaro Whittembury, regional adviser for the Comprehensive Immunization Special Program, said in a presentation on Wednesday. 'It's important to show that although at first the outbreak starts in Mennonite communities … the vast majority of cases are outside of these communities, and they are sustained in the general population.' Only a small share of confirmed cases in the Americas have identified genetic sequences, experts from the Pan American Health Organization said, and there haven't been enough identical sequences to explicitly link cases across countries. In April, Mexico issued a warning for people traveling to the US and Canada due to high measles case rates. The US Centers for Disease Control and Prevention has also stepped up its guidance for travelers, advising that anyone traveling internationally should be vaccinated with two doses of the MMR vaccine. 'Anyone who is unvaccinated is at risk and I urge everyone, but especially those who may become pregnant, to ensure they have received two doses of the MMR vaccine, which will protect both a parent and baby,' Moore said in his statement Thursday. 'This vaccine has been safely used for over 50 years and is highly effective. Two doses provide nearly 100 per cent protection.'
CNN
13 hours ago
- CNN
As measles spreads across the Americas, outbreaks in Mexico and Canada have also turned deadly
As measles cases in the United States continue to mount, neighboring countries Canada and Mexico are also experiencing significant outbreaks – all of which have been linked to at least one death. On Thursday, the chief medical officer of health of the Canadian province Ontario announced that an infant who was born prematurely with a measles infection had died. 'The infant contracted the virus before birth from their mother, who had not received the measles, mumps and rubella (MMR) vaccine,' Dr. Kieran Moore said in a statement. 'While measles may have been a contributing factor in both the premature birth and death, the infant also faced other serious medical complications unrelated to the virus.' At least four people have died from measles in Mexico in 2025, and three people have died in the US: two children in Texas and one adult in New Mexico, all of whom were unvaccinated. This years' measles outbreaks are the biggest that Canada and Mexico have seen in decades, and the World Health Organization has warned that the 'overall risk of measles in the Americas Region is considered high.' Low vaccination rates are a key driver of this elevated risk assessment, the agency said. Mexico has reported at least 1,520 measles cases as of late May, according to data from the Pan American Health Organization. Canada reached measles elimination status in 1998, meaning that there has not been continuous spread of the virus for more than a year. But there have already been more cases reported so far this year than there were in the previous 27 years combined. At least 2,755 measles cases have been reported in Canada so far this year, according to federal data that was last updated on Monday, the vast majority of those which have been in Ontario residents. And the US has reported at least 1,168 measles cases so far this year, according to federal data published Friday – nearly 80% of which are associated with an outbreak centered in West Texas that has spread to New Mexico, Oklahoma and possibly Canada. It's the second highest number of cases that the US has reported since achieving measles elimination status in 2000. Significant shares of the measles outbreaks in the US, Canada and Mexico have been concentrated in Mennonite communities that are closely connected to each other – and that have historically had low vaccination rates due largely to minimal interactions with formal health care systems. However, in a recent webinar, experts from the Pan American Health Organization did not formally link outbreaks in the three countries to each other. 'The outbreak [in Mexico] started in Chihuahua, at the heart of Mennonite communities, who were very close to Texas through the border, but they're also close to other Mennonite communities in Canada,' Dr. Alvaro Whittembury, regional adviser for the Comprehensive Immunization Special Program, said in a presentation on Wednesday. 'It's important to show that although at first the outbreak starts in Mennonite communities … the vast majority of cases are outside of these communities, and they are sustained in the general population.' Only a small share of confirmed cases in the Americas have identified genetic sequences, experts from the Pan American Health Organization said, and there haven't been enough identical sequences to explicitly link cases across countries. In April, Mexico issued a warning for people traveling to the US and Canada due to high measles case rates. The US Centers for Disease Control and Prevention has also stepped up its guidance for travelers, advising that anyone traveling internationally should be vaccinated with two doses of the MMR vaccine. 'Anyone who is unvaccinated is at risk and I urge everyone, but especially those who may become pregnant, to ensure they have received two doses of the MMR vaccine, which will protect both a parent and baby,' Moore said in his statement Thursday. 'This vaccine has been safely used for over 50 years and is highly effective. Two doses provide nearly 100 per cent protection.'
Politico
a day ago
- Politico
WHO sounds the alarm as US measles cases mount
Presented by Driving The Day WHO SPEAKS UP ON MEASLES — President Donald Trump might not care for the World Health Organization's advice, but that isn't stopping one of its top officials from warning his administration about what's at stake as measles cases accumulate in the U.S. Dr. Katherine O'Brien, the WHO's vaccines director, told POLITICO's Carmen Paun that U.S. political leaders should clearly endorse and promote measles vaccination to prevent the country from losing its disease-elimination status — and become a location that gives rise to future outbreaks that can easily spread domestically and abroad among travelers. If the disease spreads continuously for a year, it would be considered endemic for the first time in 25 years. 'It's really a sign of a country going backwards in terms of their ability to protect people,' O'Brien said. Why it matters: O'Brien said 'leadership voices really matter' when people consider medical interventions for their children. If one family is influenced enough to decline the measles, mumps and rubella vaccine for their child, that's 'one child too many,' she said, given how highly contagious the virus is. Measles is 'not just a fever and a rash that people get over,' O'Brien said. So far this year, three unvaccinated people — including two young girls — have died from the disease in the U.S. Before the most recent outbreak, the last U.S. measles death occurred in 2015. Background: HHS Secretary Robert F. Kennedy Jr. has couched his promotion of the MMR shot with statements emphasizing that vaccination is a personal choice. Before he ran for president and then entered government, Kennedy founded Children's Health Defense, an anti-vaccine nonprofit that suggests shots cause a slew of pediatric medical problems such as autism, asthma and developmental delays. Kennedy has also inaccurately asserted that the MMR vaccine contains cells from aborted fetuses and has touted supplements like vitamin A as a disease treatment. HHS has defended the secretary's measles response, calling 'claims' that he's 'spreading misinformation or undermining vaccine confidence … flat-out false.' WELCOME TO FRIDAY PULSE. I'm FDA reporter Lauren Gardner, filling in for Kelly today. Pass along your tips, scoops and feedback to lgardner@ and khooper@ and follow along @Gardner_LM or @Kelhoops. POLITICO PRO SPACE — Need an insider's guide to the politics behind the new space race? From battles over sending astronauts to Mars to the ways space companies are vying to influence regulators, this weekly newsletter decodes the personalities, policy and power shaping the final frontier. Find out more. In Congress THIRD RAIL NO MORE? Senate Republicans are considering ways to incorporate Medicare cuts into their domestic spending package to help offset its cost — a move that could divide a party that can't afford many defections to pass the president's signature legislation, POLITICO's Jordain Carney, Meredith Lee Hill and Robert King report. The House version of President Donald Trump's big beautiful bill includes cuts to Medicaid, the government health insurance program for low-income people and those with disabilities. But cuts to Medicare — which insures those 65 and older — are widely seen as politically dangerous. The idea percolated in private meetings this week as GOP leaders try to placate budget hardliners who want more spending cuts in the package ahead of a self-imposed July 4 deadline for passage. And some Republicans believe Trump supports Medicare cuts — provided they're limited to targeting 'waste, fraud and abuse' — despite the potential for backlash from rank-and-file senators and House moderates who already sank efforts to touch the program. HEADING TO THE HUMPHREY BUILDING — The Senate confirmed Jim O'Neill on Thursday in a 52-43 vote to be HHS's deputy secretary, your morning host writes. O'Neill, a George W. Bush-era HHS official who's close with early Trump supporter and tech billionaire Peter Thiel, will be the department's No. 2 official charged with managing operations. AROUND THE AGENCIES FDA'S RARE DISEASE DRUG APPROACH — The FDA's leading biologics regulator said Thursday that he was open to using alternative measurement methods when evaluating rare-disease therapies, combining what he called 'gold-standard science and common sense' in the approval process. 'We will rapidly make available therapies at the first sign or promise of biomedical success or action, but we're also going to follow up overall survival and quality of life on the back end,' Dr. Vinay Prasad, director of the FDA's Center for Biologics Evaluation and Research, said during an agency roundtable on cell and gene therapies. The remarks were notable given Prasad's history of criticizing past FDA approvals of certain treatments, including a controversial Duchenne muscular dystrophy gene therapy and certain cancer drugs, using surrogate markers. Prasad added he's often asked whether he's 'solely' interested in randomized controlled trials and said he's open to a variety of methodologies demonstrating a drug's benefit. Background: His remarks come weeks after he and Commissioner Marty Makary unveiled a new Covid-19 vaccine framework that limits approvals of future formulation changes to people 65 and older and younger individuals with an underlying condition — and requiring new RCTs to prove the shots are safe and effective for young, healthy people. Cell and gene therapies are often discussed in the context of rare diseases as the technologies can address root causes instead of solely managing symptoms. But a condition's rarity hinders a company's ability to conduct a large-scale trial for a drug candidate, an issue with which regulators and industry have long struggled. The FDA launched a rare disease 'hub' last year to better align its drug and biologics regulators in their approach to considering those therapies for the market. NIH LOOKS TO AI — The National Institutes of Health is building an AI strategy to help HHS Secretary Robert F. Kennedy Jr. target chronic disease, POLITICO's Ruth Reader reports. Principal Deputy Director Matthew Memoli announced the plan Thursday, asking the public to weigh in at the Coalition for Health AI's Innovation Summit at Stanford University. NIH wants industry to comment on both the broad approach and the specific actions the administration should take in developing the strategy. The agency plans to create a new website to highlight its AI work. 'Addressing this crisis is going to require large-scale efforts — research that's going to generate large amounts of data — and we are going to need all the tools available to us in order to try to address this,' Memoli said. Names in the News Courtney Rhodes is now head of news and media relations at the U.S. Travel Association. She was previously a spokesperson at the FDA. The Health Resources and Services Administration announced its new 34-member board of directors for the Organ Procurement and Transplantation Network. WHAT WE'RE READING House FDA appropriators advanced their fiscal 2026 spending measure Thursday for the agency and the U.S. Department of Agriculture, POLITICO's David Lim reports. Infectious disease and other medical experts fear HHS's changes to Covid-19 vaccine recommendations will make it more difficult to immunize people by complicating discussions with providers and likely leading to fewer places stocking them, Stat's Helen Branswell writes.
